SLC5A3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.55689913686297E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.6563972415895E-11 |
Normal-vs-Stage2 |
1.51650025870254E-10 |
Normal-vs-Stage3 |
3.66150443298352E-11 |
Normal-vs-Stage4 |
5.54649659534334E-11 |
Stage1-vs-Stage2 |
2.612800E-01 |
Stage1-vs-Stage3 |
5.850400E-01 |
Stage1-vs-Stage4 |
3.111800E-01 |
Stage2-vs-Stage3 |
5.398000E-01 |
Stage2-vs-Stage4 |
7.271800E-01 |
Stage3-vs-Stage4 |
7.080200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.68289843066805E-11 |
Normal-vs-AfricanAmerican |
3.34976490989902E-12 |
Normal-vs-Asian |
3.05540037714991E-10 |
Caucasian-vs-AfricanAmerican |
2.861700E-02 |
Caucasian-vs-Asian |
4.710800E-01 |
AfricanAmerican-vs-Asian |
9.767000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.57069920905906E-11 |
Normal-vs-Female |
2.41050512883589E-11 |
Male-vs-Female |
8.238400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.7292391397159E-12 |
Normal-vs-Age(41-60Yrs) |
2.44719799979976E-11 |
Normal-vs-Age(61-80Yrs) |
3.73809871945241E-11 |
Normal-vs-Age(81-100Yrs) |
3.08000003279574E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.956000E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.510200E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.630400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.035400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.265400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.088800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.76559910925312E-11 |
Normal-vs-Grade 2 |
1.08669739873335E-11 |
Normal-vs-Grade 3 |
5.23570076182978E-11 |
Normal-vs-Grade 4 |
8.68799476805293E-11 |
Grade 1-vs-Grade 2 |
8.075000E-01 |
Grade 1-vs-Grade 3 |
3.940400E-01 |
Grade 1-vs-Grade 4 |
5.098800E-01 |
Grade 2-vs-Grade 3 |
7.694400E-02 |
Grade 2-vs-Grade 4 |
2.969600E-01 |
Grade 3-vs-Grade 4 |
9.863200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.98659985631389E-11 |
Normal-vs-ccB subtype |
2.59360311005707E-11 |
ccA subtype-vs-ccB subtype |
9.019400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.95440330585939E-11 |
Normal-vs-N1 |
9.09039998830963E-09 |
N0-vs-N1 |
8.000800E-01 |
|
|